An activatable theranostic for targeted cancer therapy and imaging

S Bhuniya, S Maiti, EJ Kim, H Lee… - Angewandte …, 2014 - Wiley Online Library
A new theranostic strategy is described. It is based on the use of an “all in one” prodrug,
namely the biotinylated piperazine‐rhodol conjugate 4 a. This conjugate, which incorporates …
被引用次数：234 相关文章

An Activatable Theranostic for Targeted Cancer Therapy and Imaging

S Bhuniya, S Maiti, EJ Kim, H Lee, JL Sessler… - Angewandte Chemie …, 2014 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> A new theranostic strategy is described. It is
based on the use of an “all in one” prodrug, namely the biotinylated piperazine‐rhodol …

An Activatable Theranostic for Targeted Cancer Therapy and Imaging

S Bhuniya, S Maiti, EJ Kim, H Lee… - ANGEWANDTE …, 2014 - scholar.korea.ac.kr
A new theranostic strategy is described. It is based on the use of an all in one prodrug,
namely the biotinylated piperazine-rhodol conjugate 4a. This conjugate, which incorporates …

An Activatable Theranostic for Targeted Cancer Therapy and Imaging.

S Bhuniya, S Maiti, EJ Kim, H Lee… - Angewandte …, 2014 - search.ebscohost.com
A new theranostic strategy is described. It is based on the use of an'all in one'prodrug,
namely the biotinylated piperazine-rhodol conjugate 4 a. This conjugate, which incorporates …

An Activatable Theranostic for Targeted Cancer Therapy and Imaging

S Bhuniya, S Maiti, EJ Kim, H Lee, JL Sessler… - Angewandte Chemie …, 2014 - infona.pl
A new theranostic strategy is described. It is based on the use of an “all in one” prodrug,
namely the biotinylated piperazine‐rhodol conjugate 4 a. This conjugate, which incorporates …

An activatable theranostic for targeted cancer therapy and imaging

S Bhuniya, S Maiti, EJ Kim, H Lee… - … (International ed. in …, 2014 - pubmed.ncbi.nlm.nih.gov
A new theranostic strategy is described. It is based on the use of an" all in one" prodrug,
namely the biotinylated piperazine-rhodol conjugate 4 a. This conjugate, which incorporates …

An activatable theranostic for targeted cancer therapy and imaging.

S Bhuniya, S Maiti, EJ Kim, H Lee… - … (International ed. in …, 2014 - europepmc.org
A new theranostic strategy is described. It is based on the use of an" all in one" prodrug,
namely the biotinylated piperazine-rhodol conjugate 4 a. This conjugate, which incorporates …

[引用][C] An Activatable Theranostic for Targeted Cancer Therapy and Imaging

S Bhuniya, S Maiti, EJ Kim, H Lee… - Angewandte …, 2014 - ui.adsabs.harvard.edu
An Activatable Theranostic for Targeted Cancer Therapy and Imaging - NASA/ADS Now on
home page ads icon ads Enable full ADS view NASA/ADS An Activatable Theranostic for …

An Activatable Theranostic for Targeted Cancer Therapy and Imaging

S Bhuniya, S Maiti, EJ Kim, H Lee… - Angewandte Chemie …, 2014 - Wiley Online Library
A new theranostic strategy is described. It is based on the use of an “all in one” prodrug,
namely the biotinylated piperazine‐rhodol conjugate 4 a. This conjugate, which incorporates …

An activatable theranostic for targeted cancer therapy and imaging

S Bhuniya, S Maiti, EJ Kim, H Lee… - Angewandte Chemie …, 2014 - pure.korea.ac.kr
A new theranostic strategy is described. It is based on the use of an" all in one" prodrug,
namely the biotinylated piperazine-rhodol conjugate 4 a. This conjugate, which incorporates …